Ted Lithgow:
Generics are driving volume through mass merchandisers such as Walmart, Target, and grocery leaders like Kroger. Many of these leading generic channels sell $4-a-month prescriptions, or three for $10 90-day scripts targeted to be more affordable, and to encourage patients to come back and refill their prescriptions more often. That has fundamentally changed the dynamics in the space.
Reducing costs throughout the supply chain to the patient will always be important, but how does MWV marry economic concerns with the sophisticated compliance packages it produces?
